Cargando…

Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals

OBJECTIVES: Patients with APS are at increased risk of thromboembolism. Neutrophils have been shown to play a role in inducing thrombosis. We aimed to investigate differences in neutrophil subpopulations, their potential of activation and neutrophil extracellular trap (NET) formation comparing high...

Descripción completa

Detalles Bibliográficos
Autores principales: Mauracher, Lisa-Marie, Krall, Moritz, Roiß, Johanna, Hell, Lena, Koder, Silvia, Hofbauer, Thomas M, Gebhart, Johanna, Hayden, Hubert, Brostjan, Christine, Ay, Cihan, Pabinger, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024003/
https://www.ncbi.nlm.nih.gov/pubmed/33026085
http://dx.doi.org/10.1093/rheumatology/keaa532
_version_ 1783675221132181504
author Mauracher, Lisa-Marie
Krall, Moritz
Roiß, Johanna
Hell, Lena
Koder, Silvia
Hofbauer, Thomas M
Gebhart, Johanna
Hayden, Hubert
Brostjan, Christine
Ay, Cihan
Pabinger, Ingrid
author_facet Mauracher, Lisa-Marie
Krall, Moritz
Roiß, Johanna
Hell, Lena
Koder, Silvia
Hofbauer, Thomas M
Gebhart, Johanna
Hayden, Hubert
Brostjan, Christine
Ay, Cihan
Pabinger, Ingrid
author_sort Mauracher, Lisa-Marie
collection PubMed
description OBJECTIVES: Patients with APS are at increased risk of thromboembolism. Neutrophils have been shown to play a role in inducing thrombosis. We aimed to investigate differences in neutrophil subpopulations, their potential of activation and neutrophil extracellular trap (NET) formation comparing high and low-density neutrophils (HDNs/LDNs) as well as subpopulations in patients with APS and controls to gain deeper insight into their potential role in thrombotic manifestations in patients with APS. METHODS: HDNs and LDNs of 20 patients with APS and 20 healthy donors were isolated by density gradient centrifugation and stimulated. Neutrophil subpopulations, their activation and NET release were assessed by flow cytometry. RESULTS: LDNs of both groups showed higher baseline activation, lower response to stimulation (regulation of activation markers CD11b/CD66b), but higher NET formation compared with HDNs. In patients with APS, the absolute number of LDNs was higher compared with controls. HDNs of APS patients showed higher spontaneous activation [%CD11b high: median (interquartile range): 2.78% (0.58–10.24) vs 0.56% (0.19–1.37)] and response to stimulation with ionomycin compared with HDNs of healthy donors [%CD11b high: 98.20 (61.08–99.13) vs 35.50% (13.50–93.85)], whereas no difference was found in LDNs. NET formation was increased in patients’ HDNs upon stimulation. CONCLUSION: HDNs and LDNs act differently, unstimulated and upon various stimulations in both healthy controls and APS patients. Differences in HDNs and LDNs between patients with APS and healthy controls indicate that neutrophils may enhance the risk of thrombosis in these patients and could thus be a target for prevention of thrombosis in APS.
format Online
Article
Text
id pubmed-8024003
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-80240032021-04-13 Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals Mauracher, Lisa-Marie Krall, Moritz Roiß, Johanna Hell, Lena Koder, Silvia Hofbauer, Thomas M Gebhart, Johanna Hayden, Hubert Brostjan, Christine Ay, Cihan Pabinger, Ingrid Rheumatology (Oxford) Clinical Science OBJECTIVES: Patients with APS are at increased risk of thromboembolism. Neutrophils have been shown to play a role in inducing thrombosis. We aimed to investigate differences in neutrophil subpopulations, their potential of activation and neutrophil extracellular trap (NET) formation comparing high and low-density neutrophils (HDNs/LDNs) as well as subpopulations in patients with APS and controls to gain deeper insight into their potential role in thrombotic manifestations in patients with APS. METHODS: HDNs and LDNs of 20 patients with APS and 20 healthy donors were isolated by density gradient centrifugation and stimulated. Neutrophil subpopulations, their activation and NET release were assessed by flow cytometry. RESULTS: LDNs of both groups showed higher baseline activation, lower response to stimulation (regulation of activation markers CD11b/CD66b), but higher NET formation compared with HDNs. In patients with APS, the absolute number of LDNs was higher compared with controls. HDNs of APS patients showed higher spontaneous activation [%CD11b high: median (interquartile range): 2.78% (0.58–10.24) vs 0.56% (0.19–1.37)] and response to stimulation with ionomycin compared with HDNs of healthy donors [%CD11b high: 98.20 (61.08–99.13) vs 35.50% (13.50–93.85)], whereas no difference was found in LDNs. NET formation was increased in patients’ HDNs upon stimulation. CONCLUSION: HDNs and LDNs act differently, unstimulated and upon various stimulations in both healthy controls and APS patients. Differences in HDNs and LDNs between patients with APS and healthy controls indicate that neutrophils may enhance the risk of thrombosis in these patients and could thus be a target for prevention of thrombosis in APS. Oxford University Press 2020-10-07 /pmc/articles/PMC8024003/ /pubmed/33026085 http://dx.doi.org/10.1093/rheumatology/keaa532 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Clinical Science
Mauracher, Lisa-Marie
Krall, Moritz
Roiß, Johanna
Hell, Lena
Koder, Silvia
Hofbauer, Thomas M
Gebhart, Johanna
Hayden, Hubert
Brostjan, Christine
Ay, Cihan
Pabinger, Ingrid
Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals
title Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals
title_full Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals
title_fullStr Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals
title_full_unstemmed Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals
title_short Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals
title_sort neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024003/
https://www.ncbi.nlm.nih.gov/pubmed/33026085
http://dx.doi.org/10.1093/rheumatology/keaa532
work_keys_str_mv AT mauracherlisamarie neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals
AT krallmoritz neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals
AT roißjohanna neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals
AT helllena neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals
AT kodersilvia neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals
AT hofbauerthomasm neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals
AT gebhartjohanna neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals
AT haydenhubert neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals
AT brostjanchristine neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals
AT aycihan neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals
AT pabingeringrid neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals